expert reaction to conference abstract about a phase 2 trial of a new weight loss injection, CBL-514, and levels of subcutaneous and visceral fat, presented at the European Association for the Study ...
Ähnliche Seiten
expert reaction to trial of new amylin-based weight-loss drug petrelintide, noting fewer side effects than GLP-1-based drugs | Science Media Centre
expert reaction to a systematic review and meta-analysis looking at preconception, pregnancy, and postnatal use of GLP-1 RAs in women with diabetes | Science Media Centre
expert reaction to study examining incidence of type 1 diabetes in children receiving rotavirus vaccine; secondary analysis suggests vaccine not cause of observed 11% relative increase | Science Medi...
expert reaction to a systematic review and meta-analysis of GLP-1 RA exposure in the periconceptional period and adverse obstetric outcomes | Science Media Centre